ID

12768

Beschreibung

Trial of Sirolimus and Methotrexate in Relapsed/Refractory Lymphoblastic Leukemia and Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT01162551

Link

https://clinicaltrials.gov/show/NCT01162551

Stichworte

Versionen (1)
  1. 21.12.15 21.12.15 -
Hochgeladen am

21. Dezember 2015

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Cancer NCT01162551

Englisch

Eligibility Cancer NCT01162551

1 Formulare  
  1. StudyEvent: Eligibility
    1. Eligibility Cancer NCT01162551
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients </= 25 years of age, at time of enrollment, with second or greater relapse of all or nhl. for all must have histologic diagnosis with >10% blasts in the marrow and for lymphoblastic lymphoma or peripheral t-cell lymphoma must have radiologic or physical evidence of recurrence.
Beschreibung

age; Acute lymphocytic leukemia; recurrence

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0023449
UMLS CUI [3]
C0034897
lansky > 50% or karnofsky > 50%
Beschreibung

Lansky Play-Performance Status; Karnofsky Performance Status

Datentyp

boolean

Alias
UMLS CUI [1]
C1522275
UMLS CUI [2]
C0206065
negative pregnancy test
Beschreibung

Pregnancy test negative

Datentyp

boolean

Alias
UMLS CUI [1]
C0427780
creatinine clearance or radioisotope gfr > 70ml/min/m2 or serum creatinine based on age /gender
Beschreibung

creatinine clearance; age; gender

Datentyp

boolean

Alias
UMLS CUI [1]
C0373595
UMLS CUI [2]
C0001779
UMLS CUI [3]
C0079399
pulse ox >94%
Beschreibung

pulse oximetry

Datentyp

boolean

Alias
UMLS CUI [1]
C0034108
total bilirubin <1.5 x normal for age
Beschreibung

total bilirubin

Datentyp

boolean

Alias
UMLS CUI [1]
C0201913
alt < 5 x normal for age
Beschreibung

Alanine Transaminase

Datentyp

boolean

Alias
UMLS CUI [1]
C1557189
albumin > 2g/dl
Beschreibung

albumin

Datentyp

boolean

Alias
UMLS CUI [1]
C0201838
shortening fraction by echo > 28% or ejection fraction > 50% by gated radionuclide study
Beschreibung

ejection fraction

Datentyp

boolean

Alias
UMLS CUI [1]
C0489482
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
patient has known allergies to sirolimus,fk-506 or mtor inhibitors
Beschreibung

hypersensitivity sirolimus

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0072980
patient is taking other investigational anti-neoplastic drugs
Beschreibung

investigational anti-neoplastic drugs other

Datentyp

boolean

Alias
UMLS CUI [1]
C1875339
patient received no myelosuppressive chemo within 14 days
Beschreibung

chemotherapy myelosuppressive

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3665472
UMLS CUI [1,2]
C1513793
< 14 days have elapsed since local palliative xrt (small port) < 28 days since prior craniospinal xrt or 50% radiation of pelvis <28 days if other substantial bm radiation
Beschreibung

radiotherapy palliative

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0034619
UMLS CUI [1,2]
C1285530
hematopoietic growth factors within 7 days of entry (except erythropoietin.)
Beschreibung

hematopoietic growth factors

Datentyp

boolean

Alias
UMLS CUI [1]
C0079490
patient has taken any biologic agents within 14 days
Beschreibung

drug biologic

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0205460
post bmt/sct - evidence of active gvhd, at least > 3 months must have elapsed
Beschreibung

Graft-versus-host disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0018133
patient has uncontrolled infection (if patients with fungal disease, stable for < 14 days and patients with bacteremia without negative blood culture
Beschreibung

bacteremia; infection uncontrolled

Datentyp

boolean

Alias
UMLS CUI [1]
C0004610
UMLS CUI [2,1]
C3714514
UMLS CUI [2,2]
C0205318
existing non-hematologic toxicities > grade 2
Beschreibung

toxicity

Datentyp

boolean

Alias
UMLS CUI [1]
C0600688
use of steroids or hydroxyurea is permitted upto 14 days prior to entry.
Beschreibung

steroids; hydroxyurea

Datentyp

boolean

Alias
UMLS CUI [1]
C0038317
UMLS CUI [2]
C0020402
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Cancer NCT01162551

1 Formulare
  1. StudyEvent: Eligibility
    1. Eligibility Cancer NCT01162551
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
age; Acute lymphocytic leukemia; recurrence
Item
patients </= 25 years of age, at time of enrollment, with second or greater relapse of all or nhl. for all must have histologic diagnosis with >10% blasts in the marrow and for lymphoblastic lymphoma or peripheral t-cell lymphoma must have radiologic or physical evidence of recurrence.
boolean
C0001779 (UMLS CUI [1])
C0023449 (UMLS CUI [2])
C0034897 (UMLS CUI [3])
Lansky Play-Performance Status; Karnofsky Performance Status
Item
lansky > 50% or karnofsky > 50%
boolean
C1522275 (UMLS CUI [1])
C0206065 (UMLS CUI [2])
Pregnancy test negative
Item
negative pregnancy test
boolean
C0427780 (UMLS CUI [1])
creatinine clearance; age; gender
Item
creatinine clearance or radioisotope gfr > 70ml/min/m2 or serum creatinine based on age /gender
boolean
C0373595 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0079399 (UMLS CUI [3])
pulse oximetry
Item
pulse ox >94%
boolean
C0034108 (UMLS CUI [1])
total bilirubin
Item
total bilirubin <1.5 x normal for age
boolean
C0201913 (UMLS CUI [1])
Alanine Transaminase
Item
alt < 5 x normal for age
boolean
C1557189 (UMLS CUI [1])
albumin
Item
albumin > 2g/dl
boolean
C0201838 (UMLS CUI [1])
ejection fraction
Item
shortening fraction by echo > 28% or ejection fraction > 50% by gated radionuclide study
boolean
C0489482 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
hypersensitivity sirolimus
Item
patient has known allergies to sirolimus,fk-506 or mtor inhibitors
boolean
C0020517 (UMLS CUI [1,1])
C0072980 (UMLS CUI [1,2])
investigational anti-neoplastic drugs other
Item
patient is taking other investigational anti-neoplastic drugs
boolean
C1875339 (UMLS CUI [1])
chemotherapy myelosuppressive
Item
patient received no myelosuppressive chemo within 14 days
boolean
C3665472 (UMLS CUI [1,1])
C1513793 (UMLS CUI [1,2])
radiotherapy palliative
Item
< 14 days have elapsed since local palliative xrt (small port) < 28 days since prior craniospinal xrt or 50% radiation of pelvis <28 days if other substantial bm radiation
boolean
C0034619 (UMLS CUI [1,1])
C1285530 (UMLS CUI [1,2])
hematopoietic growth factors
Item
hematopoietic growth factors within 7 days of entry (except erythropoietin.)
boolean
C0079490 (UMLS CUI [1])
drug biologic
Item
patient has taken any biologic agents within 14 days
boolean
C0013227 (UMLS CUI [1,1])
C0205460 (UMLS CUI [1,2])
Graft-versus-host disease
Item
post bmt/sct - evidence of active gvhd, at least > 3 months must have elapsed
boolean
C0018133 (UMLS CUI [1])
bacteremia; infection uncontrolled
Item
patient has uncontrolled infection (if patients with fungal disease, stable for < 14 days and patients with bacteremia without negative blood culture
boolean
C0004610 (UMLS CUI [1])
C3714514 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
toxicity
Item
existing non-hematologic toxicities > grade 2
boolean
C0600688 (UMLS CUI [1])
steroids; hydroxyurea
Item
use of steroids or hydroxyurea is permitted upto 14 days prior to entry.
boolean
C0038317 (UMLS CUI [1])
C0020402 (UMLS CUI [2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video